NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

介入放射線學(IVR)的全球市場 - 成長,趨勢,預測(2019年∼2024年)

Interventional Radiology Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence Pvt Ltd 商品編碼 707341
出版日期 內容資訊 英文 114 Pages
商品交期: 2-3個工作天內
價格
介入放射線學(IVR)的全球市場 - 成長,趨勢,預測(2019年∼2024年) Interventional Radiology Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年08月01日內容資訊: 英文 114 Pages
簡介

成本效益高的解決方案和住院的短期化,微創手術的偏好高漲等使治療迅速化,手術後出院的案例增加。由於影像診斷技術的創新進行使得診斷時即時提供體內影像變得可能,促進介入放射線學(IVR)市場成長。

本報告提供全球介入放射線學(IVR)市場調查,市場概要,各產品、手術、用途、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 慢性疾病的罹患率和盛行率的上升
    • 介入放射線學(IVR)設備的技術進步
  • 市場阻礙因素
    • 高輻射暴露的風險
    • 設備成本高
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第5章 市場區隔

  • 各產品
    • MRI系統
    • 超音波影像系統
    • CT掃描機
    • 血管造影術系統
    • 螢光透視系統
    • 切片檢查設備
    • 其他
  • 各手術
    • 血管成形術
    • 血管造影術
    • 切片檢查、引流
    • 栓塞術
    • 血栓溶解術
    • 椎體成形術
    • 腎瘺造設術
    • 其他
  • 各用途
    • 循環系統
    • 泌尿系統
    • 腫瘤
    • 腸胃
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Carestream Health
    • Esaote S.P.A.
    • GE Healthcare
    • 日立Medical
    • Hologic Inc.
    • Koninklijke Philips N.V.
    • 島津製作所
    • Siemens AG
    • 東芝MedicalSystems
    • Samsung Medison

第7章 市場機會及未來趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 62817

There is a rising trend of minimally-invasive procedures, owing to the cost-effective solution and lesser hospital stay. With the help of minimally-invasive techniques, patients are quickly treated and are often discharged from the hospital the very same day. Most of the minimally-invasive procedures require imaging technologies.

Innovation in the imaging technologies, which provides real-time images to the surgeons to show a comprehensive view of internal organs, while diagnosing, is driving the interventional radiology market.

Chronic diseases are ongoing, generally incurable illnesses or conditions, such as heart disease, asthma, cancer, and diabetes. Cardiovascular diseases are the major causes of death, globally. Until recent years, treating heart disease meant opening the patient's chest to directly access the heart, through surgery, which was expensive and often exposed the patient to a high risk of infection.

According to the WHO 2017 report, an estimated 17.9 million people die from CVDs every year, representing 31% of all the global deaths. Of these deaths, an estimated 7.4 million are due to coronary heart disease and 6.7 million are due to stroke. These alarming numbers demand the development of safe and effective interventional procedures.

The increasing preference for minimally-invasive procedures and the prevalence of chronic diseases are driving the interventional radiology market. The market is expected to grow steadily, owing to effective interventional procedures performed in lieu of surgery.

Key Market Trends

Application in Oncology is Expected to Witness the High Growth over the Forecast Period

Interventional radiology involves the use of medical imaging to see inside the body coupled with minimally invasive techniques to diagnose and treat cancer, as well as provide relief from symptoms. Surgeons and doctors use tools such as catheters and needles to address a large variety of medical conditions that would have required surgery in the past. The most common diseases treated with this technique include cancers of the lung, liver, kidney, and bone. But this is a growing field, and researchers are exploring its use in treating a variety of other cancer types.

Moreover, the incidence of cancer in recent years has increased. Cancer Research UK suggests that the population suffering from cancer is expected to increase in the future. As per the report, if recent trends in incidence of major cancers and population growth are consistent, it is predicted there will be 27.5 million new cancer cases worldwide each year by 2040, as compared to 17 million in 2018. This factor is expected to increase the demand for minimally invasive procedures like interventional radiology, which will boost the market growth.

North America to Dominate the Market, during the Forecast Period

The growing burden of chronic diseases, owing to changing lifestyles and the rising need for cost-effective, minimally-invasive interventional procedures, are driving the market studied, in the United States. Cardiac catheterization is used extensively, for the diagnosis and treatment of various heart disorders. More than a million cardiac catheterizations and angiographic procedures are conducted every year, in the United States.

Several interventional radiology procedures can be used to treat cancer patients. For example, transarterial chemoembolization can cut off the blood supply to a tumor, while radiofrequency ablation (RFA) and microwave ablation may damage the cancerous tissue itself. According to the National Cancer Institute, in 2018, an estimated 1,735,350 new cases of cancer were expected to be diagnosed in the United States, and 609,640 people were likely to die from the disease.

The rising prevalence of chronic conditions, such as cancer, diabetes, and others, and the prospects of minimally-invasive, targeted treatments, using imaging guidance, are driving the market in the United States.

Competitive Landscape

The interventional radiology market is highly competitive and consists of global as well as local players, across the world. Some of the companies that currently dominate the market include GE Healthcare, Hitachi Medical Systems, Koninklijke Philips NV, Siemens AG, and Shimadzu Corporation, among others. However, with technological advancements, it is expected that few small and mid-sized companies will also penetrate the market, in the future.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidence and Prevalence of Chronic Diseases
    • 4.2.2 Technological Advancements in Interventional Radiology Devices
  • 4.3 Market Restraints
    • 4.3.1 Risk of High Radiation Exposure
    • 4.3.2 High Cost of Equipment
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 MRI Systems
    • 5.1.2 Ultrasound Imaging Systems
    • 5.1.3 CT Scanners
    • 5.1.4 Angiography Systems
    • 5.1.5 Fluoroscopy Systems
    • 5.1.6 Biopsy Devices
    • 5.1.7 Other Products
  • 5.2 By Procedure
    • 5.2.1 Angioplasty
    • 5.2.2 Angiography
    • 5.2.3 Biopsy and Drainage
    • 5.2.4 Embolization
    • 5.2.5 Thrombolysis
    • 5.2.6 Other Procedures
  • 5.3 By Application
    • 5.3.1 Cardiology
    • 5.3.2 Urology & Nephrology
    • 5.3.3 Oncology
    • 5.3.4 Gastroenterology
    • 5.3.5 Other Applications
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East & Africa
      • 5.4.4.1 Gulf Cooperation Council
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East & Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Carestream Health
    • 6.1.2 Esaote SPA
    • 6.1.3 GE Healthcare
    • 6.1.4 Hitachi Medical Corporation
    • 6.1.5 Hologic Inc.
    • 6.1.6 Koninklijke Philips NV
    • 6.1.7 Shimadzu Corporation
    • 6.1.8 Siemens AG
    • 6.1.9 Toshiba Medical Systems Corporation
    • 6.1.10 Samsung Medison

7 MARKET OPPORTUNITIES AND FUTURE TRENDS